|Bid||33.510 x 4600|
|Ask||33.520 x 7800|
|Day's Range||33.335 - 33.700|
|52 Week Range||29.830 - 37.390|
|PE Ratio (TTM)||28.24|
|Dividend & Yield||1.28 (3.84%)|
|1y Target Est||N/A|
Analysts downgrade PFE as they suggest that the big pharma stock has limited drivers of upside.
Citigroup on Thursday initiated coverage of electric car maker Tesla at neutral/high risk. Analysts also upgraded PC and printer maker HP and athletic apparel vendor Nike.
Shares of Pfizer (PFE) have gained 5.1% since closing at $32 on June 7, and the stock even looks like it had been making a run for the top of its recent range. In fact, they call themselves "long-time supporters" of the company, and see "opportunities for upside over the long term." So why are they downgrading Pfizer?